Maya GoldmanIllustration: Tiffany Herring/AxiosThe Food and Drug Administration on Monday is launching an agency-wide generative AI tool aimed at helping scientific reviewers, investigators and others streamline their work, according to details shared with Axios. Why it matters: The model, dubbed "Elsa," is being rolled out weeks ahead of schedule and is designed to help with tasks such as summarizing adverse events to support drug safety profiles, and to generate code for databases. The big pic...